PM exposure during pregnancy affects childhood asthma via placental epigenetic changes: Neuronal differentiation and

Hyo-Bin Kim1, Si Hyeon Lee2, Dae Yeol Yang3

  • 1Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul, Republic of Korea.

Insights

Exposure to particulate matter (PM) during pregnancy increases childhood asthma risk. Placental epigenetic changes, specifically DNA hypermethylation in key pathways, are identified as a significant mechanism linking PM exposure to asthma development in offspring.

Area of Science:

  • Environmental Health
  • Epigenetics
  • Pediatric Asthma

Background:

  • Particulate matter (PM) exposure during pregnancy is linked to increased childhood asthma risk.
  • The underlying placental mechanisms remain largely unknown.
  • Epigenetic dysregulation in the placenta is a potential mediator.

Purpose of the Study:

  • To investigate placental epigenetic mechanisms linking prenatal PM exposure to childhood asthma susceptibility.
  • To analyze genome-wide methylation and gene expression in placental samples.
  • To identify specific genes and pathways involved in PM-induced asthma.

Main Methods:

  • Analysis of two Korean birth cohorts (COCOA, PSKC) with data on PM10 exposure and childhood asthma at age seven.
  • Genome-wide methylation profiling and gene expression analysis in placental samples from the COCOA cohort.
  • Land-use regression models for estimating prenatal PM10 exposure.

Main Results:

  • High prenatal PM10 exposure was associated with increased risk of current asthma and bronchial hyperresponsiveness (BHR).
  • Significant hypermethylation was observed in genes related to neuronal differentiation, proliferation, and Notch signaling pathways in children with high PM exposure.
  • A predictive model using methylation levels demonstrated high accuracy (AUC 0.96 and 0.93) for PM-related asthma.

Conclusions:

  • Prenatal PM10 exposure influences offspring asthma development through placental DNA hypermethylation.
  • Neuronal differentiation, proliferation, and Notch signaling pathways are implicated in this process.
  • Placental methylation patterns can serve as predictive biomarkers for PM-related asthma.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
350
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
232